Livongo Health has secured $20 million in Series B funding from investors including Kleiner Perkins Caufield &
Byers (KPCB), DFJ and previous investor General Catalyst. Dr. Beth Seidenberg, General Partner at KPCB, and Emily Melton, Partner at DFJ, will be joining Livongo Health's Board of Directors.